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Abstract
Background: Chronic spinal cord injury (SCI) can lead to an insidious decline in motor and
sensory function in individuals even years after the initial injury and is accompanied by a slow and
progressive cytoarchitectural destruction. At present, no pathological mechanisms satisfactorily
explain the ongoing degeneration.
Methods:  Adult female Sprague-Dawley rats were anesthetized laminectomized at T10 and
received spinal cord contusion injuries with a force of 250 kilodynes using an Infinite Horizon
Impactor. Animals were randomly distributed into 5 groups and killed 1 (n = 4), 28 (n = 4), 120 (n
= 4), 450 (n = 5), or 540 (n = 5) days after injury. Morphometric and immunohistochemical studies
were then performed on 1 mm block sections, 6 mm cranial and 6 mm caudal to the lesion
epicenter. The SPSS 11.5 t test was used to determine differences between quantitative measures.
Results: Here, we document the first report of an ascending central canal dilation and progressive
ependymal disruption cranial to the epicenter of injury in a contusion model of chronic SCI, which
was characterized by extensive dural fibrosis and intraparenchymal cystic cavitation. Expansion of
the central canal lumen beyond a critical diameter corresponded with ependymal cell ciliary loss,
an empirically predictable thinning of the ependymal region, and a decrease in cell proliferation in
the ependymal region. Large, aneurysmal dilations of the central canal were accompanied by
disruptions in the ependymal layer, periependymal edema and gliosis, and destruction of the
adjacent neuropil.
Conclusion: Cells of the ependymal region play an important role in CSF homeostasis, cellular
signaling and wound repair in the spinal cord. The possible effects of this ascending pathology on
ependymal function are discussed. Our studies suggest central canal dilation and ependymal region
disruption as steps in the pathogenesis of chronic SCI, identify central canal dilation as a marker of
chronic SCI and provide novel targets for therapeutic intervention.
Background
By the end of the next decade, 300,000 people will be liv-
ing with chronic spinal cord injury in the US alone [1].
Advances in medical and rehabilitative care have
improved survival rates for these individuals, but many
experience clinical decline even years after the initial
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injury. Clinical decline is often accompanied by a slow
and progressive cavitation of the central spinal cord,
known as post-traumatic syringomyelia (for a review, see
[2]). The pathogenesis of this disease remains poorly
understood.
Derangements of cerebrospinal fluid (CSF) dynamics fol-
lowing spinal cord injury are thought to play a role in the
initiation and propagation of syringomyelic cysts [3-15].
Normally, CSF circulates in the subarachnoid space,
traverses the spinal cord several times a day and exhibits a
craniocaudal flow pattern influenced by the cardiac cycle
[16]. Some spinal fluid, driven by systolic pulsations, is
thought to enter the substance of the cord via the Vir-
chow-Robin perivascular spaces and flow toward the cen-
tral canal [17,18], an enigmatic structure of the central
spinal cord believed to function as a CSF pathway. Indeed,
Storer and colleagues have suggested that fluid flow
through the central canal may comprise a 'sink' function
whereby harmful metabolites are removed from the cord
[19]. Others believe the spinal cord itself produces extra-
cellular fluid, whose egress toward the subarachnoid
space or central canal depends on the pressure differential
between the two compartments [16].
Following SCI, normal CSF dynamics may be distorted by
a number of possible mechanisms, including subarach-
noid CSF outflow obstructions [2,12], changes in compli-
ance of the subarachnoid space [6], or elevated intraspinal
pressures [9]. Altered CSF dynamics are believed to result
in localized spinal cord edema, known as the presyrinx
state [20] that subsequently gives rise to intraspinal cavi-
ties and cysts.
The propagation of intraspinal cavities requires a driving
force sufficient to propel fluid via a one-way valve mecha-
nism into the cysts and cavities, which often contain fluid
at a higher pressure than the subarachnoid space [21].
Proposed driving forces include cardiac pulsations along
vessels [4,17], postural changes and valsalva movements
[22], coalescence of microcysts [23] and elevated intrasp-
inal pressures [9]. We would additionally suggest consid-
eration of the transient hypertensive episodes of
autonomic dysreflexia (for a review, see [24,25]) and the
oncotic pressure of central canal fluid as potential driving
forces.
The histological features of syringomyelia have been
reproduced in experimental models of the disease. Exper-
imental syringomyelia was first induced reliably with
intraspinal injections of the irritant kaolin, producing his-
tological results similar to syringomyelia and, in many
respects, acute hydrocephalus [14]. Subsequent models
utilized intraspinal injections of excitotoxic compounds
and produced pathological results via a physiologically
relevant mechanism consistent with the neurochemical
milieu known to accompany SCI [5,26,27]. Both experi-
mental models suffer the limitation of being non-trau-
matic [26] and require the administration of exogenous
agents [28]. Mathematical models of syrinx formation
allow the study of pressure wave propagations in an ideal-
ized cerebrospinal fluid system, but suffer the limitation
of not taking into account spinal cord parenchymal
changes that may influence patterns of dilation [3,4,8-
10,13,29].
Here, we utilized a clinically relevant contusion model of
chronic SCI in hopes of elucidating novel features of this
insidious disease. Reminiscent of human syringomyelia,
chronic spinal cord injured animals developed cysts and
glial-lined cavities of the central spinal cord near the epi-
center of injury, which was characterized by extensive
dural fibrosis. A prominent ascending and progressive
dilation of the central canal lumen cranial to the epicenter
of injury was evident over time, presumably due to disten-
sile forces within the canal, and was accompanied by
changes in the surrounding ependyma and periependy-
mal tissues. By Laplace's law, we reasoned that dilations in
the central canal lumen would result in a wall tension
being exerted on the ependymal cells lining the canal that
would increase with both the radius and pressure within
the canal. We therefore focused our study on the his-
topathological changes in the ependymal region and per-
iependymal tissues that accompanied the progressive
dilation of the central canal.
Methods
Spinal cord injury
Adult female Sprague-Dawley rats (n = 22) aged 6–8
weeks and weighing 200–220 grams were anesthetized
with intraperitoneal injections of Ketamine (80 mg/kg;
Phoenix Pharmaceuticals, Inc. St. Joseph, MO) and Xyla-
zine (10 mg/kg; Phoenix Pharmaceuticals, Inc., St. Joseph,
MO). The skin overlying the T8-T11 vertebral levels was
shaved and disinfected with provodone scrubs. An inci-
sion was made over the T8-T11 spinous processes expos-
ing the underlying paravertebral muscles. Blunt dissection
was utilized to expose the transverse processes at T9-T11,
and a complete laminectomy was performed at T10. The
spinous processes of T9 and T11 were clamped and stabi-
lized using a stereotactic device and a contusion injury
with a force of 250 kilodynes was induced using an Infi-
nite Horizon Impactor (Precision Systems and Instrumen-
tation LLC, Fairfax, VA). The overlying muscle was then
sutured in layers and the skin stapled with stainless steel
wound clips. Post-operative care included bolus injec-
tions of subcutaneous saline and prophylactic enro-
floxacin (2.5 mg/kg/day; Bayer Corporation, Shawnee
Mission, KS). Animals received manual bladder expres-
sion twice daily and were inspected for signs of infection,BMC Neurology 2007, 7:30 http://www.biomedcentral.com/1471-2377/7/30
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dehydration or autophagia, with appropriate veterinary
assistance as needed. All surgical interventions and pre-
and post-operative care were conducted in accordance
with institutional guidelines.
Histology
Animals were randomly distributed into 5 groups and
killed 1 (n = 4), 28 (n = 4), 120 (n = 4), 450 (n = 5), or
540 (n = 5) days after injury. Animals in the 1, 28, 120 and
450-day groups were terminally anesthetized and killed
by intracardiac perfusion with 4% glutaraldehyde (Fisher
Scientific International Inc., Pittsburgh, PA) for resin
processing. Animals in the 540-day group received intra-
peritoneal injections of bromodeoxyuridine (BrdU, 100
mg/kg; Sigma-Aldrich, St. Louis, MO) daily over a two
week period prior to terminal anesthesia and killing by
intracardiac perfusion with 4% paraformaldehyde for
immunohistochemical processing; these spinal cords was
dissected and cut in the transverse plane into twelve 1 mm
blocks, six blocks cranial to and six blocks caudal to the
lesion epicenter. Spinal cords from the 1, 28, 120 and
450-day groups were post-fixed in 4% glutaraldehyde for
72 hours, rinsed in 0.1 M phosphate buffer pH 7.4 for 30
minutes, exposed to 1% OsO4 (Electron Microscopy Sci-
ences, Fort Washington, PA), dehydrated in ascending
alcohols, soaked in propylene oxide (Electron Microscopy
Sciences, Fort Washington, PA), and embedded in Spurr
resin (Electron Microscopy Sciences, Fort Washington,
PA), as previously described [30,31]. Transverse semi-thin
(1 um) sections were cut from the cranial face of each
block, stained with alkaline toluidine blue (Sigma, St.
Louis, MO), cover slipped and examined by light micros-
copy on an Olympus AX-80 microscope using Olympus
Microsuite B3SV software (Olympus America Inc.,
Melville, NY). For electron microscopy, blocks were
trimmed and sections were cut at 100 nm, mounted on
copper grids, stained with uranyl acetate and lead citrate,
and viewed under a Hitachi EM 600 electron microscope
at 75 kV (Hitachi High Technologies America Inc.,
Schaumburg, IL). For the 540-day group, tissue blocks
were cut with a cryostat into 20 µm sections and mounted
on gelatin-coated slides for BrdU immunohistochemistry
and hematoxylin/eosin staining (Sigma-Aldrich, St. Louis,
MO).
For BrdU immunostaining, slide mounted sections from
the 540 day group were denatured for 30 minutes using 2
N HCL (Fisher Scientific, Hampton, NH) and then incu-
bated for 30 minutes in 0.1 M phosphate buffer pH 7.4
with 2% bovine serum albumin (Sigma-Aldrich, St. Louis,
MO). Sections were incubated overnight at 4 degrees Cel-
sius with a mouse monoclonal anti-BrdU immunoglobu-
lin (Zymed Laboratories, San Francisco, CA). Bound
antibody was visualized by incubation in goat anti-mouse
Alexa Fluor 594 secondary antibody (Invitrogen,
Carlsbad, CA) for 1 hour. Finally, slides were coverslipped
and viewed using an Olympus AX-80 microscope using
Olympus Microsuite B3SV software (Olympus America
Inc., Melville, NY). Standard immunohistochemical con-
trols were utilized and untreated sections and no-primary
antibody controls were observed for evidence of autofluo-
rescense.
Sections adjacent to those used for BrdU immunostaining
were stained with hematoxylin and eosin according to
standard protocol [32]. Hematoxylin/eosin stained sec-
tions were observed to verify the presence and characteris-
tics of ependymal region nuclei and to rule out
misidentification of infiltrating autofluoresecent cells
such as macrophages.
Quantitative analysis of the ependymal region
Five transverse sections sampled at successive 1 mm incre-
ments cranial and caudal to the lesion epicenter were ana-
lyzed from each animal. Sections were excluded from
analyses in cases where secondary non-ependymal lined
cavities disrupted the integrity of the central canal. Sec-
tions were viewed and digitally photographed with an
Olympus AX-80 microscope using Olympus Microsuite
B3SV software (Olympus America Inc., Melville, NY).
Ependymal region area, central canal luminal area, central
canal perimeter and ependymal region nuclear count
measurements were made using the Olympus Microsuite
B3SV software (Olympus America Inc., Melville, NY).
Only clearly stained, round to oval nuclei were counted.
Average ependymal region thickness was calculated as the
average of eight linear measurements, taken at 8 compass
points, from the apical-most ependymal cell processes in
contact with the central canal lumen to the basal-most
ependymal cell process in contact with the basal lamina of
the ependymal region. The ependymal region cellular
density was determined by dividing the total ependymal
region nuclear count by the corresponding central canal
luminal perimeter. Cellular coverage of the central canal
was determined by multiplying ependymal region cellular
density by the diameter of an average ependymal cell. The
SPSS 11.5 t test was used to determine differences between
quantitative measures.
Results
By 450 days after spinal cord injury, all rats developed
cysts and glial-lined cavitations of the central spinal cord
near the epicenter of injury, which was characterized by
extensive dural fibrosis. An ascending dilation of central
canal lumen was noted up to 5 mm cranial to the injury
epicenter that was not evident to this extent caudal to the
injury (Figure 1). A statistically significant (p < 0.05) dif-
ference in central canal perimeter was noted between the
distances 3 mm cranial and 3 mm caudal to the lesion epi-
center, as well as 5 mm cranial and 5 mm caudal theBMC Neurology 2007, 7:30 http://www.biomedcentral.com/1471-2377/7/30
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lesion epicenter, compared to normal, uninjured spinal
cords at the same vertebral level.
The development of central cystic cavitations at the epi-
center of injury was accompanied by qualitative and
quantitative trends in the central canal rostral to the epi-
center of injury (Figure 2, Figure 3). Changes were noted
in central canal luminal perimeter, the ependymal region
thickness and periependymal tissue consistency. Toluid-
ine blue staining revealed progressive dilation of the cen-
tral canal lumen immediately (1 mm) cranial to epicenter
of injury over time (Figure 2A–D), accompanied by pro-
gressive thinning of the ependymal region, ependymal
cell ciliary loss as well as periependymal edema, gliosis
and destruction of the surrounding neuropil (Figure 2E–
H). Quantitative analysis of these changes over time
revealed a progressive increase in dilation of the central
canal lumen (Figure 3A), a progressive decrease in the
average ependymal region thickness (Figure 3B), and a
progressive decrease in the average ependymal region cel-
lular density (Figure 3C). There was a statistically signifi-
cant increase in the total ependymal region nuclear count
from day 1 to day 28 (data not shown), which was
reflected in an increasing cellular density from day 1 to
day 28, but this latter measure did not achieve statistical
significance. A comparison of central canal perimeter and
ependymal region cellular density at 1 mm cranial to the
lesion epicenter for time points 1 and 28 days versus day
450 indicated a statistically significant (p < 0.05) negative
correlation. Pooling of data from all time points and dis-
tances rostral to the lesion epicenter indicated that the
thickness of the ependymal region varied inversely with
the size of the central canal (Figure 3D).
Changes over time in the central canal lumen and epend-
ymal region cellular density were also evident in the
region of spinal cord extending 1–5 mm cranial to the
lesion epicenter. Enlargement of the central canal lumen
from 1 to 450 days post-injury was evident at 1 mm (Fig-
ure 4A–D), 3 mm (Figure 4E–H) and 5 mm (Figure 4I–L)
from the lesion epicenter; the increase in central canal
lumen size was greater closer to the lesion epicenter and,
at late time points, spread progressively to rostral spinal
cord segments. Quantitative analysis of central canal
lumen perimeter and ependymal region cellular density
indicated relatively stable values from 1–5 mm cranial to
the lesion epicenter at 1 day (Figure 5A) and 28 days (Fig-
ure 5B) post injury. By day 120 post-injury (Figure 5C),
marked and varied dilations of the central canal lumen
perimeter were evident at all points cranial to the lesion
epicenter. At 450 days post-injury (Figure 5D), the central
canal lumen was markedly dilated 1 mm cranial to the
epicenter of the injury and was accompanied by diminish-
ing dilations of the central canal lumen in adjacent spinal
cord segments up to 5 mm cranial to the epicenter of
injury. Notably, an inverse relationship between central
canal size and ependymal region thickness was evident
Quantification of the central canal perimeter +/- 1 mm-5 mm from the lesion epicenter 450 days after injury, with representa- tive toluidine blue stained transverse sections of rat spinal cord for each distance Figure 1
Quantification of the central canal perimeter +/- 1 mm-5 mm from the lesion epicenter 450 days after injury, with representa-
tive toluidine blue stained transverse sections of rat spinal cord for each distance. Extensive dural fibrosis and intraparenchymal 
cavitations are evident at the epicenter of the injury, which are reminiscent of human syringomyelia. Central canal dilation is 
more marked cranial to the epicenter of injury and is evident up to 5 mm cranial to epicenter of the injury. Asterisks indicate 
significance at p < 0.05. Magnification = 10×.BMC Neurology 2007, 7:30 http://www.biomedcentral.com/1471-2377/7/30
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over the 1 to 3 mm distance at 450 days, similar to the
trend seen at 1 mm over time.
By 450 days post-injury and beyond, marked dilations of
the central canal lumen perimeter were evident at all
points cranial to the lesion epicenter, with a progressive
increase in the central canal lumen perimeter toward the
lesion epicenter (Figure 6A–C). Associated with the pro-
gressive increase in central canal lumen perimeter toward
the lesion epicenter was a progressive loss of ependymal
cilia and thinning of the ependymal region (Figure 6E–F).
Quantitative changes over time of the post-traumatic central  canal lumen, ependymal and periependymal regions at 1 mm  cranial to the lesion epicenter Figure 3
Quantitative changes over time of the post-traumatic central 
canal lumen, ependymal and periependymal regions at 1 mm 
cranial to the lesion epicenter. (A) Quantitation of central 
canal perimeter 1 mm cranial to the lesion epicenter indi-
cates a progressive increase from day 1 to day 450 following 
injury. (B) Quantitation of ependymal region thickness 1 mm 
cranial to the lesion epicenter indicates a progressive 
decrease from day 1 to day 450 following injury. (C) Quanti-
tation of ependymal region nuclear density 1 mm cranial to 
the lesion epicenter indicates an increase from day 1 to day 
28 following injury, then a progressive decrease from day 28 
to day 450 following injury. (D) The relation of ependymal 
region thickness to perimeter of the central canal lumen at all 
time points. Error bars represent standard error.
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Qualitative changes over time of the post-traumatic central  canal lumen, ependymal and periependymal regions at 1 mm  cranial to the lesion epicenter Figure 2
Qualitative changes over time of the post-traumatic central 
canal lumen, ependymal and periependymal regions at 1 mm 
cranial to the lesion epicenter. Toluidine blue stained trans-
verse sections of contused rat spinal cords 1 mm cranial to 
the lesion epicenter are shown in A-H. Low magnification 
images reveal a progressively increasing central canal lumen 
from day 1 (A), day 28 (B), day 120 (C) and day 450 (D) fol-
lowing injury. High magnification images reveal progressive 
thinning of the ependymal region, ependymal ciliary loss, and 
periependymal edema from day 1 (E), day 28 (F), day 120 
(G) and day 450 (H) following injury. Magnification = 40× for 
A-D, 300× for E-H.BMC Neurology 2007, 7:30 http://www.biomedcentral.com/1471-2377/7/30
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In order to assess the effects of these structural changes in
the ependymal region cells on the proliferative capacity of
ependymal region cells, BrdU was administered. A
decrease in BrdU immunostaining was found within the
ependymal region that accompanied large, aneurysmal
dilations of the central canal lumen (Figure 6G–I). Serial
sections adjacent to the BrdU immunostained sections
were hematoxylin and eosin stained (Figure 6J–L), reveal-
ing discontinuity of the ependymal layer surrounding the
large, aneurysmal dilations of the central canal at 1 mm
cranial to the lesion epicenter (arrow in Figure 6L).
Comparison of the central canal luminal area with the
absolute number of cells within the ependymal region
revealed a bell-shaped distribution, where the absolute
number of cells within the ependymal region increased
with enlarging central canal area up until a critical area of
approximately 40,000 µm2 (corresponding to a diameter
of approximately 220 µm); thereafter, the absolute cell
number decreased (Figure 7A). While the absolute nuclear
count returned to pre-peak values, plotting the extent of
cellular coverage of the central canal cell revealed an
incomplete cellular coverage of the canal (<1 cell) with
diameters greater than 220 um (Figure 7B). Transverse
toluidine blue stained sections of the adult rat spinal cord
450 days after injury demonstrated that mild (Figure 7C)
and moderate (Figure 7D) dilations of the central canal
were consistently associated with an ependymal region
that was several nuclear layers thick that increased up to a
critical diameter; thereafter, the large, aneurysmal dila-
Qualitative changes over time of the post-traumatic central canal lumen and ependymal region cellular density at 1 mm-5 mm  cranial to the lesion epicenter Figure 4
Qualitative changes over time of the post-traumatic central canal lumen and ependymal region cellular density at 1 mm-5 mm 
cranial to the lesion epicenter. Toluidine blue stained transverse sections of contused rat spinal cords from day 1, day 28, day 
120 and day 450 following injury at 1 mm (A-D), 3 mm (E-H) and 5 mm (I-L) cranial to the lesion epicenter. Magnification = 
40× for A-L.BMC Neurology 2007, 7:30 http://www.biomedcentral.com/1471-2377/7/30
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tions of the central canal (Figure 7E) were consistently
associated with an ependymal region that displayed a flat-
tened ependymal cell layer, ependymal ciliary loss and a
disrupted continuity of cells lining the canal. In all cases,
such ependymal regions were juxtaposed to a neuropil
with robust degeneration, including edema, gliosis, and
macrophage infiltration.
Discussion
The development of successful therapeutic interventions
for chronic spinal cord injury necessitates a greater under-
standing of the pathogenesis of the disease, including the
delineation of its histopathological stages. Here, we
describe and provide a temporal framework for several
histopathological stages of SCI disease progression.
Spinal cord injured rats demonstrated an ascending and
progressive dilation of the central canal lumen cranial to
the lesion epicenter over time, which was associated with
progressive degeneration of the ependymal and peri-
ependymal regions. The central canal is an enigmatic
structure of the central spinal cord, believed to function as
a CSF pathway. Central canal dilation has been noted in
autopsy studies of syringomyelic patients [33] and an
ultrastructural analysis of post-traumatic syrinxes revealed
ependymal remnants lining portions of the cavity [34].
Using serial MR imaging, Takamura and colleagues have
documented a case of post-traumatic progressive central
canal dilation leading to syrinx formation in a young
adult [35], but until now this feature has not been fully
appreciated in an experimental model of the disease. In
our studies, mild to moderate dilations of the central
canal lumen were not associated with gross degeneration
of the ependymal and peri-ependymal regions, whereas
large aneurysmal dilations of the central canal lumen were
consistently associated with a circumferential degenera-
tion of the ependymal and peri-ependymal regions, indi-
cating that gray matter degeneration in chronic SCI is
preceded by changes in the ependymal region and/or
intraluminal cerebrospinal fluid (CSF) dynamics. This
pathogenic sequence is consistent with that seen in devel-
opment of chronic hydrocephalus and suggests that dis-
tensile forces within fluid compartments resulting from
obstruction may be common feature of the two diseases.
Furthermore, the central canal dilation we observed was
ascending and asymmetric from the point of injury sug-
gesting a pathologic process beyond the mere loss of vol-
ume of surrounding tissue. In spinal cord injury, this
ascending pathology may represent a tertiary form of
injury arising from disturbances in CSF flow near the epi-
center of injury arising from dural fibrosis. Moreover, the
slow and progressive nature of the phenomenon may
result from transient spikes in hydrostatic pressure, lead-
ing to a water hammer effect, and/or changes in intralumi-
nal oncotic pressures that would precede ischemic
Quantitative changes over time of the post-traumatic central  canal lumen and ependymal region cellular density at 1 mm-5  mm cranial to the lesion epicenter Figure 5
Quantitative changes over time of the post-traumatic central 
canal lumen and ependymal region cellular density at 1 mm-5 
mm cranial to the lesion epicenter. Quantitation of central 
canal perimeter and ependymal region thickness from 1 mm-
5 mm cranial to the lesion epicenter at day 1 (A), day 28 (B), 
day 120 (C), and day 450 (D) following injury. Error bars 
represent standard error.
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changes in the cord. In humans, the cystic and cavitary
lesions of syringomyelia are known to progress over time
and thus the transmission of distensile pressures along the
central canal may represent a mechanism by which these
lesions can spread to adjacent, uninjured spinal cord seg-
ments. Our rodent data indicate that the progression
occurred cranial to the lesion epicenter, whereas in
humans progression occurs both cranial and caudal to the
lesion epicenter. This difference may be influenced by the
effects of gravity on the upright posture of humans.
Spinal cord injured rats demonstrated progressive epend-
ymal cell ciliary loss cranial to the lesion epicenter, and a
loss of ependymal cell cilia with large dilations of the cen-
tral canal lumen. Cilia are specialized projections of
ependymal cells that promote the flow of CSF within the
central canal. Ependymal ciliary loss is known to predis-
pose to hydrocephalus[36] and is a feature of the disease
[37]. Therefore, this loss of ependymal cell cilia in the spi-
nal cord may result in altered local CSF homeostasis,
resulting in an accumulation of toxic metabolites and
Transverse sections of the adult rat spinal cord at late time points after injury Figure 6
Transverse sections of the adult rat spinal cord at late time points after injury. Toluidine blue staining 450 days after injury 5 
mm (A), 3 mm (B), and 1 mm (C) from the lesion epicenter reveals a progressive dilation of the central canal. Higher power 
magnification of the cells lining the central canal 5 mm (D), 3 mm (E), and 1 mm (F) from the lesion epicenter reveals a pro-
gressive loss of cilia and flattening of ependymal cells at 1 mm from the lesion epicenter (F); these cells also exhibit a more 
euchromatic appearing nucleus. (G) BrdU immunolabeling of the central canal at 540 days after injury 5 mm from lesion epi-
center reveals BrdU immunoreactivity with a mild dilation of the central canal. (H) BrdU immunolabeling of the central canal 3 
mm from lesion epicenter also reveals BrdU immunoreactivity with a moderate dilation of the central canal, but with more dis-
persion of cells around the canal. (I) BrdU immunolabeling of the central canal 1 mm from lesion epicenter shows diminished 
BrdU reactivity with severe dilation of the central canal. Hematoxylin and eosin staining at 540 days after injury 5 mm (J), 3 mm 
(K), and 1 mm (L) from the lesion epicenter reveals a progressive dilation of the central canal; note that the continuity of cells 
bordering the central canal is disrupted 1 mm from the lesion epicenter (arrow in L). Magnification = 40× for A&B, 30× for C, 
300× for D-F, 40× for G-L.BMC Neurology 2007, 7:30 http://www.biomedcentral.com/1471-2377/7/30
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oncotic pressures, which could result in damage to the
ependymal and periependymal regions. Notably, the
ependymal cell layer disruption noted in our study is rem-
iniscent of the ependymal denudation that proceeds the
development of severe hydrocephalus in the hyh mouse
[38].
At late time points, large aneurysmal dilations of the cen-
tral canal lumen were accompanied by denudation of the
ependymal cell layer. Normally, ependymal cells form a
pseudostratified monolayer of epithelium that regulates
fluid and electrolyte balance between the CSF and
neuropil [39]. Disruption of the ependymal layer could
therefore result in the loss of a protective epithelium. This
loss of integrity and competence of the canal could result
in exposure of the adjacent grey and white matter to
hydrostatic and oncotic pressure gradients, leading to a
dissection of stagnant CSF from within the canal into the
gray and white matter of the cord, leading to structural
and conductive deficits. Indeed, fluid from syringomyelia
cysts is known to differ from normal CSF [40], usually
having a higher protein content [41] and prolonged expo-
sure of peri-ependymal tissues to this microenvironment
may lead to its degeneration. In our studies, areas of
ependymal denudation were consistently opposed to
regions of peri-ependymal edema, gliosis, macrophage
infiltration and loss of neuropil. Furthermore, local dis-
ruption of the blood brain barrier may contribute to the
edema [40] and subsequent ischemic injury, but may also
represent a source of inflammatory molecules and plasma
The progressive dilation of the central canal with time after spinal cord injury results in a loss of ependymal region cellular den- sity Figure 7
The progressive dilation of the central canal with time after spinal cord injury results in a loss of ependymal region cellular den-
sity. (A) Total ependymal region cell counts increase with enlarging central canal area up until a critical point. Thereafter, the 
absolute cell number decreases. (B) Cellular coverage of the central canal similarly decreases with enlarging central canal. 
Transverse toluidine blue stained sections of the adult rat spinal cord 450 days after injury demonstrating the evolution of the 
ependymal region cell changes are depicted in C-E. Mild (C) and moderate (D) central canal dilations are associated with an 
increasing ependymal region nuclear count. Large, aneurysmal dilation of the central canal (E) is accompanied by flattening of 
the ependymal cell layer, ependymal ciliary loss and disruptions in the continuity of cells lining the canal. Note the periependy-
mal edema and gliosis, macrophage infiltration and loss of adjacent neuropil. Magnification = 60× for C-E.BMC Neurology 2007, 7:30 http://www.biomedcentral.com/1471-2377/7/30
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proteins that may adversely influence the microenviron-
ment of nearby cells, including cells with stem/progenitor
characteristics, thereby influencing their viability and pat-
terns of differentiation.
It is intriguing to note that large, aneurysmal dilations of
the central canal lumen were also associated with
decreased proliferation of ependymal region cells. Cells of
the ependymal region are vestiges of neuroepithelial cells
that give rise to neurons and glia during mammalian
development [42] and are known to orchestrate the regen-
erative response in tailed amphibians [43]. Ependymal
region cells have been shown to proliferate [42,44-46]
and migrate [47-49] following spinal cord injury. This
finding has led some authors to speculate on their role in
endogenous repair in humans [50]. Indeed, the kinetics of
ependymal region cell proliferation and differentiation
have been correlated with the recovery of lower limb
motor function in rats following contusion injuries [46].
Of note, neural stem cells have been isolated from the
CNS [47,51,52], including regions near the central canal
[53]. Unlike the subventricular zone, the prototypical
stem cell niche of the CNS (for a review, see [54]),
multipotent cells of the ependymal region appear
restricted to glial lineages [46,47,49]. Gliogenesis near the
central canal includes the generation of ependymal cells
[44], reactive astrocytes [46,47,49], oligodendrocyte pre-
cursors [55] and microglia [56]. Glia are supportive cells
of the CNS and are critical for maintaining the structural
and functional integrity of the spinal cord after injury
[57]. Even reactive astrocytes, long thought to be inhibi-
tory to axonal regeneration, appear to play a role in repair
of SCI lesions [46,58,59]. Therefore, it stands to reason
that disruption of the ependymal stromal epithelium,
along with periependymal stem/progenitor cells, may rep-
resent a heretofore unrecognized pathogenic mechanism
in spinal cord injury, which would hinder gliogenesis in
the ependymal region and subsequently wound repair in
the spinal cord. Indeed, the progressive disruption of this
cell layer, through mechanical and cytotoxic means, could
represent a disease mechanism that tips the balance
between injury and repair in the spinal cord toward fur-
ther cytoarchitectural destruction of lesions over time. In
principle, this conceptualized disease process should be
investigated in other multipotent niches as a basis for
understanding related degenerative disorders and seque-
lae.
Conclusion
This study documents an ascending and progressive cen-
tral canal dilation and ependymal region destruction ros-
tral to the epicenter of injury in a contusion model of SCI,
which was characterized by extensive dural fibrosis near
the epicenter of injury. We suggest progressive ependymal
region disruption as a novel step in the pathogenesis of
chronic spinal cord injury, identify central canal dilation
as a potential marker of chronic spinal cord injury and
document the ependymal region as a therapeutic target,
through cellular rescue or replacement. Our findings share
many histological features with chronic hydrocephalus
[37] and suggest that early restoration of favorable CSF
hydrodynamics in SCI may prevent further degeneration
and provide an environment more hospitable for repair.
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